Alignment Healthcare (NASDAQ:ALHC) President Dawn Christine Maroney Sells 122,707 Shares of Stock

Key Points

• Alignment Healthcare President Dawn Maroney sold 122,707 shares at an average price of $12.68, generating approximately $1.56 million. The sale reduced her direct stake by 13.38% and was made to cover tax withholding tied to vested equity awards.
• ALHC shares fell 1.2% to $12.61, near their 12-month low of $12.39 and below both the 50-day and 200-day moving averages. The stock has a market capitalization of about $2.62 billion.
• The company recently exceeded quarterly earnings and revenue expectations, reporting $0.17 in adjusted EPS and $1.34 billion in revenue, up 31.6% year over year. Analysts maintain a “Moderate Buy” consensus rating with an average price target of $23.60.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) President Dawn Maroney sold 122,707 shares of the stock in a transaction on Friday, September 11th. The stock was sold at an average price of $12.68, for a total transaction of $1,555,924.76. Following the completion of the sale, the president directly owned 794,606 shares of the company's stock, valued at $10,075,604.08. The trade was a 13.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, June 15th, Dawn Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $19.55, for a total transaction of $586,500.00.

Alignment Healthcare Stock Down 1.2%

Shares of NASDAQ:ALHC traded down $0.15 during midday trading on Friday, hitting $12.61. 6,075,652 shares of the company's stock traded hands, compared to its average volume of 3,839,666. The firm's fifty day moving average price is $16.17 and its two-hundred day moving average price is $18.03. The company has a debt-to-equity ratio of 1.22, a quick ratio of 1.70 and a current ratio of 1.70. Alignment Healthcare, Inc. has a twelve month low of $12.39 and a twelve month high of $25.12. The company has a market cap of $2.62 billion, a PE ratio of 66.37 and a beta of 1.11.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its earnings results on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The company had revenue of $1.34 billion during the quarter, compared to the consensus estimate of $1.31 billion. During the same quarter in the prior year, the business earned $0.07 earnings per share. The company's revenue was up 31.6% compared to the same quarter last year. On average, equities research analysts anticipate that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

Institutional Trading of Alignment Healthcare

A number of hedge funds have recently made changes to their positions in the stock. WINTON GROUP Ltd bought a new stake in shares of Alignment Healthcare in the second quarter worth $1,164,000. Arizona State Retirement System grew its position in shares of Alignment Healthcare by 15.8% in the 2nd quarter. Arizona State Retirement System now owns 53,553 shares of the company's stock worth $1,275,000 after acquiring an additional 7,318 shares in the last quarter. Nykredit A S acquired a new position in shares of Alignment Healthcare in the 2nd quarter worth approximately $36,000. Corient Private Wealth LP increased its holdings in shares of Alignment Healthcare by 128.2% in the 2nd quarter. Corient Private Wealth LP now owns 136,505 shares of the company's stock valued at $3,250,000 after acquiring an additional 76,677 shares during the last quarter. Finally, HighTower Advisors LLC acquired a new stake in shares of Alignment Healthcare during the 2nd quarter valued at approximately $755,000. Institutional investors and hedge funds own 86.19% of the company's stock.

Analysts Set New Price Targets

Several brokerages have issued reports on ALHC. UBS Group reaffirmed a "neutral" rating on shares of Alignment Healthcare in a research report on Wednesday, July 8th. Raymond James Financial cut shares of Alignment Healthcare from a "strong-buy" rating to an "outperform" rating and reduced their target price for the stock from $22.00 to $19.00 in a research report on Monday, August 3rd. Barclays decreased their target price on shares of Alignment Healthcare from $19.00 to $16.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 26th. KeyCorp reaffirmed an "overweight" rating on shares of Alignment Healthcare in a report on Wednesday, June 10th. Finally, Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Alignment Healthcare in a research note on Tuesday, August 4th. Seven research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $23.60.

About Alignment Healthcare

Alignment Healthcare, Inc NASDAQ: ALHC is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.